12:00 AM
 | 
Jan 24, 2000
 |  BC Week In Review  |  Company News  |  Other News

Vion other research news

VION received a $750,000 Phase II SBIR grant from the National Cancer Institute to engineer its bacterial...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >